Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | PEPD | P12955 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.32 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.32 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29193619 | 0.98 | CAMK2A (0.39) | CAMK2ACA4PEPDTSHRGPR84 | |
| SCHEMBL14918857 | 0.91 | GPR84 (0.44) | CA4GPR84FFAR1FFAR4ENPP2 | |
| SCHEMBL2201756 | 0.87 | TSHR (0.43) | CA4PEPDTSHRENPP2LPAR3 | |
| Ammonia Solution, Strong SCHEMBL1408904 | 0.85 | CA4 (0.42) | CA4PEPDTSHRENPP2LPAR3 | |
| SCHEMBL27725186 | 0.85 | CA4 (0.42) | CA4PEPDTSHRENPP2LPAR3 | |
| SCHEMBL12189869 | 0.85 | CA4 (0.42) | CA4PEPD | |
| SCHEMBL1514715 | 0.83 | CAMK2A (0.42) | CAMK2ATSHRGPR84FFAR1FFAR4 | |
| SCHEMBL285627 | 0.82 | CA4 (0.48) | CA4PEPDTSHR | |
| Ethylene Glycol SCHEMBL8003023 | 0.80 | LPAR3 (0.50) | ENPP2LPAR3LPAR1LPAR6LPAR4 | |
| Ethylene Glycol SCHEMBL28820001 | 0.80 | LPAR3 (0.50) | ENPP2LPAR3LPAR1LPAR6LPAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320531-A1 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 1,4-BUTANEDIOL RELATED THERETO | AGAIN BIO APS (DK) | 2025-10-16 | — | — | US | claimed |
| US-12264354-B2 | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto | GENOMATICA, INC. (US) | 2025-04-01 | — | — | US | claimed |
| CN-118006521-A | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol and producing related 1, 4-butanediol | 基因组股份公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117904018-A | Alcohol dehydrogenase variants | 基因组股份公司 | 2024-04-19 | — | — | CN | claimed |
| US-20240052379-A1 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 1,4-BUTANEDIOL RELATED THERETO | AGAIN BIO APS (DK) | 2024-02-15 | — | — | US | claimed |
| EP-4056706-A1 | MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND RELATED METHODS | Genomatica, Inc. (US) | 2022-09-14 | — | — | EP | claimed |
| US-11401534-B2 | Microorganisms for the production of 1,4- butanediol and related methods | GENOMATICA, INC. (US) | 2022-08-02 | — | — | US | claimed |
| US-20160319313-A1 | MICROORGANISMS AND METHODS FOR THE COPRODUCTION 1,4-BUTANEDIOL AND GAMMA-BUTYROLACTONE | AGAIN BIO APS (DK) | 2016-11-03 | — | — | US | claimed |
| EP-2534141-B1 | PROCESS FOR GAMMA-BUTYROLACTONE PRODUCTION | METABOLIX INC (US) | 2016-04-20 | — | — | EP | claimed |
| US-20150376152-A1 | Process for Ultra Pure Chemical Production from Biobased Raw Starting Materials | METABOLIX, INC. (US) | 2015-12-31 | — | — | US | claimed |
| WO-2013023140-A1 | POST PROCESS PURIFICATION FOR GAMMA-BUTYROLACTONE PRODUCTION | METABOLIX, INC. (US) | 2013-02-14 | — | — | WO | claimed |
| US-20130034884-A1 | MICROORGANISMS FOR PRODUCING 1,4-BUTANEDIOL AND METHODS RELATED THERETO | GENOMATICA, INC. (US) | 2013-02-07 | — | — | US | claimed |
| WO-2012177943-A1 | MICROORGANISMS FOR PRODUCING 1,4-BUTANEDIOL AND METHODS RELATED THERETO | GENOMATICA, INC. (US) | 2012-12-27 | — | — | WO | claimed |
| EP-2534141-A1 | PROCESS FOR GAMMA-BUTYROLACTONE PRODUCTION | METABOLIX, INC. (US) | 2012-12-19 | — | — | EP | claimed |
| WO-2012170793-A1 | BIOREFINERY PROCESS FOR THF PRODUCTION | METABOLIX, INC. (US) | 2012-12-13 | — | — | WO | claimed |
| US-8178327-B2 | Microorganisms for the production of 1,4-butanediol | GENOMATICA, INC. (US) | 2012-05-15 | — | — | US | claimed |
| US-8067214-B2 | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors | GENOMATICA, INC. (US) | 2011-11-29 | — | — | US | claimed |
| US-20110217742-A1 | MICROORGANISMS AND METHODS FOR THE COPRODUCTION 1,4-BUTANEDIOL AND GAMMA-BUTYROLACTONE | AGAIN BIO APS (DK) | 2011-09-08 | — | — | US | claimed |
| WO-2011100601-A1 | PROCESS FOR GAMMA-BUTYROLACTONE PRODUCTION | METABOLIX, INC. (US) | 2011-08-18 | — | — | WO | claimed |
| WO-2011066076-A1 | MICROORGANISMS AND METHODS FOR THE COPRODUCTION OF 1,4-BUTANEDIOL AND GAMMA-BUTYROLACTONE | GENOMATICA, INC. (US) | 2011-06-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376152-A1 | Process for Ultra Pure Chemical Production from Biobased Raw Starting Materials | MCCC2, CYP51A1, HSD17B7 | CAMK2A 1054/4885CA4 499/4885PEPD 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.